The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia
Open accessAbstract
Treatment-resistant schizophrenia (TRS) affects around one-third of individuals with schizophrenia. Although a number of sociodemographic and clinical predictors of TRS have been identified, data on the genetic risk of TRS are sparse. We aimed to investigate the association between a polygenic risk score for schizophrenia and treatment resistance in patients with schizophrenia. We conducted a nationwide, population-based follow-up study among all Danish individuals born after 1981 and with an incident diagnosis of schizophrenia between 1999 and 2007. Based on genome-wide data polygenic risk scores for schizophrenia were calculated in 862 individuals with schizophrenia. TRS was defined as either clozapine initiation or at least 2 periods of different antipsychotic monotherapies and still being hospitalized. We estimated hazard rate ratios (HRs) for TRS in relation to the polygenic risk score while adjusting for population stratification, age, sex, geographical area at birth, clinical treatment setting, psychiatric comorbidity, and calendar year. Among the 862 individuals with schizophrenia, 181 (21.0%) met criteria for TRS during 4674 person-years of follow-up. We found no significant association between the polygenic risk score and TRS, adjusted HR = 1.13 (95% CI: 0.95-1.35). Based on these results, the use of the polygenic risk score for schizophrenia to identify individuals with TRS is at present inadequate to be of clinical utility at the individual patient level. Future research should include larger genetic samples in combination with non-genetic markers. Moreover, a TRS-specific developed polygenic risk score would be of great interest towards early prediction of TRS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Efforts to identify TRS based on genetics and neuroimaging are on-going, 94, 95”
From Treatment resistance in psychiatry: state of the art and new directions (2022) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Self-citationCommon polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
The Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
The Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589
Power and predictive accuracy of polygenic risk scores
Dudbridge, F. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003348 · Cited by 1,509
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Vilhjálmsson, B. J., Yang, J., Finucane, H. K., Gusev, A., Lindström, S., Ripke, S., Genovese, G., Loh, P.-R., Bhatia, G., Do, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.001 · Cited by 1,303
Self-citationResearch Review: Polygenic methods and their application to psychiatric traits
Wray, N. R., Lee, S. H., Mehta, D., Vinkhuyzen, A. A. E., Dudbridge, F., & Middeldorp, C. M. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12295 · Cited by 666
Research works printed but not linked: 5
- NICE Project Team GDG, 2014, NICE Guideline 178. Psychosis and Schizophrenia in Adults: Treatment and Management
- National Collaborating Centre for Mental H, 2009, Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update). NICE Clinical Guidelines, No. 82
- 2009, Kliniske retningslinier for behandling med antipsykotika [Clinical Guidelines for Treatment With Antipsychotics]
- 1998, Behandling med antipsykotika. Vejledende retningslinjer. [Treatment With Antipsychotics. Guidelines]
- , : å [ ]; 2014, Baggrundsnotat for medicinsk behandling af psykotiske tilstande [Background Note for Medical Treatment of Psychotic States]
Cited by
McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3360 · Cited by 1,481
Treatment resistance in psychiatry: state of the art and new directions
Howes, O. D., Thase, M. E., & Pillinger, T. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01200-3 · Cited by 413
Pedersen, C. B., Bybjerg-Grauholm, J., Pedersen, M. G., Grove, J., Agerbo, E., Bækvad-Hansen, M., Poulsen, J. B., Hansen, C. S., McGrath, J. J., Als, T. D., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.196 · Cited by 338
Self-citationGenomic findings in schizophrenia and their implications
Owen, M. J., Legge, S. E., Rees, E., Walters, J. T. R., & O’Donovan, M. C. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02293-8 · Cited by 180
Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences
Bogdan, R., Baranger, D. A. A., & Agrawal, A. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084847 · Cited by 163
“Mixed evidence also exists for an effect of SCZ-PRS on treatment response (Wimberley et al., 2017b, Li et al., 2017).”
Metadata
- Authors
- Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T.
- Affiliations
- Aarhus University (DK)
- King's College London (GB)
- Corresponding author
- Wimberley, Theresa
- ORCID
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-10
- Volume
- 43
- Issue
- 5
- Pages
- 1064-1069
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- PMC
- PMC5581885
- OpenAlex
- W2586701058
- Cited by
- 89
- References
- 30
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 9 · 2020: 8 · 2019: 14 · 2018: 9 · 2017: 3
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Schizophrenia Bulletin (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research (FP7/2007–2013)
- King's College London
- European Commission (279227)
- Lundbeckfonden (R155-2014-1724)
- H. Lundbeck A/S (R155-2014-1724)
- Medical Research Council (MR/L011794/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- treatment-resistant schizophrenia, polygenic risk score
- MeSH terms
- Adolescent, Adult, Denmark, Drug Resistance, Female, Follow-Up Studies, Humans, Male, Registries, Risk, Schizophrenia, Antipsychotic Agents, Genetic Predisposition to Disease, Multifactorial Inheritance, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/sbx007
- The paper
- Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T. (2017). Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbx007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.